Merck & Co., Inc. (ETR:6MK)
Germany · Delayed Price · Currency is EUR | Market Cap | 231.17B |
| Revenue (ttm) | 54.75B |
| Net Income (ttm) | 16.22B |
| Shares Out | n/a |
| EPS (ttm) | 6.44 |
| PE Ratio | 14.25 |
| Forward PE | 11.89 |
| Dividend | 2.86 (3.07%) |
| Ex-Dividend Date | Dec 15, 2025 |
| Volume | 8,713 |
| Average Volume | 5,288 |
| Open | 93.30 |
| Previous Close | 93.30 |
| Day's Range | 92.30 - 93.80 |
| 52-Week Range | 65.50 - 99.10 |
| Beta | 0.30 |
| RSI | 71.50 |
| Earnings Date | Feb 3, 2026 |
About Merck & Co.
Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, B... [Read more]
Financial Performance
In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.
Financial numbers in USD Financial StatementsNews
Merck (MRK) Faces Impact from New CDC Immunization Guidelines
Merck (MRK) Faces Impact from New CDC Immunization Guidelines
US Cuts Childhood Vaccine Schedule To 11 Core Shots— What It Means For Vaccine Makers Like Merck And GSK
In a move that could impact vaccine-makers like Merck & Co. Inc. (NYSE: MRK), GSK plc (NYSE: GSK), the U.S. government has decided to massively reduce the number of vaccines it recommends for every ...
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
The highest-yielding stocks in the Dow are Verizon, Chevron, and Merck, but should you buy any of them?
Merck to Participate in the 44th Annual J.P. Morgan Healthcare Conference
RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Participate in the 44th Annual J.P. Morgan Healthcare Conference.
Top 10 High-Yield Dividend Stocks For January 2026
My high-yield dividend watchlist aims for quality stocks at attractive valuations, with a long-term CAGR target of 12%. In December 2025, the watchlist gained 0.03%, outperforming VYM and SPY, though ...
Dogs Of The Dow: 10 High-Yield Stocks With Dividends Up To 6.8% - Including Several Warren Buffett Favorites
The Dow Jones Industrial Average hit record all-time highs in 2025 with many of the components ending the year higher. Along with serving as a well-known barometer of overall market health, the index ...
Dogs Of The Dow: 10 High-Yield Stocks With Dividends Up To 6.8% - Including Several Warren Buffett Favorites
The Dow Jones Industrial Average hit record all-time highs in 2025 with many of the components ending the year higher. Along with serving as a well-known barometer of overall market health, the index ...
Merck: A Pharma Giant Trading At A Decade-Low Valuation While Executing Its Post-Keytruda Playbook
Merck: Framework For Success
Merck is strong in cash and balance sheet and will have continued growth in their highest-margin product while being greatly undervalued. See why MRK stock is a Buy.
Merck: A Post-2028 Slowdown Doesn't Kill The Long-Term Thesis
Merck stock earns a cautious "Buy." Learn more about its valuation, Keytruda risks, pipeline potential, and long-term growth.
Dow Movers: NVDA, MRK
In early trading on Monday, shares of Merck topped the list of the day's best performing Dow Jones Industrial Average components, trading up 0.6%. Year to date, Merck registers a 8.0% gain. And the wo...
Merck & Co Unusual Options Activity
High-rolling investors have positioned themselves bullish on Merck & Co (NYSE: MRK), and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's ...
Cidara: Merck's Acquisition Based On CD388 Flu Prevention Potential
3 Drug Stocks to Buy at a Discount
Eli Lilly is currently leading the market for GLP-1 drugs, taking the pole position from Novo Nordisk. Novo Nordisk just got approval for a GLP-1 pill, which could again upend the dynamics for weight ...
These are the most overbought S&P 500 stocks as 2026 approaches
Wall Street's most overbought stocks for the last full trading week of the year included Merck & Co. and S&P Global.
Looking Into Merck & Co Inc's Recent Short Interest
Merck & Co Inc's (NYSE: MRK) short interest as a percent of float has risen 16.78% since its last report. According to exchange reported data, there are now 37.16 million shares sold short , which is...
Why Merck (MRK) Outpaced the Stock Market Today
The latest trading day saw Merck (MRK) settling at $106.45, representing a +1.34% change from its previous close.
Check Out What Whales Are Doing With MRK
Whales with a lot of money to spend have taken a noticeably bearish stance on Merck & Co . Looking at options history for Merck & Co (NYSE: MRK) we detected 13 trades. If we consider the specifics of...
Wall Street Analysts Think Merck (MRK) Is a Good Investment: Is It?
Based on the average brokerage recommendation (ABR), Merck (MRK) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this hig...
Merck: Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor
First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER study In MANEUVER, pimicotinib significantly improved objective response rate at week 25 ...
Notable analyst calls this week: Paypal, Rivian and Merck among top picks
Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal
President Donald Trump and nine major pharmaceutical companies announced agreements to lower the cost of medications for cash payers and the government’s Medicaid program on Friday, bringing U.S. cost...
Top Research Reports for NVIDIA, Netflix & Merck
New research highlights NVIDIA's AI-driven growth, Netflix's ad-tier momentum and Merck's pipeline progress, while microcaps also make the cut.
FDA Prioritizes Merck (MRK) Products for Enhanced Patient Access
FDA Prioritizes Merck (MRK) Products for Enhanced Patient Access
Nine pharmaceutical companies including Bristol-Myers Squibb, GSK and Merck agreed to lower the prices that certain federal government programs and patients pay
The companies, including Bristol-Myers Squibb, GSK and Merck, would avoid potential U.S. tariffs in return.